Latest Sofinnova Investments, Inc. Stock Portfolio
$1.92Billion– No. of Holdings #72
Sofinnova Investments, Inc. Performance:
2024 Q2: -8.01%YTD: 10.38%2023: 6.36%
Performance for 2024 Q2 is -8.01%, and YTD is 10.38%, and 2023 is 6.36%.
About Sofinnova Investments, Inc. and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Sofinnova Investments, Inc. reported an equity portfolio of $1.9 Billions as of 30 Jun, 2024.
The top stock holdings of Sofinnova Investments, Inc. are NTRA, VERA, . The fund has invested 8.7% of it's portfolio in NATERA INC and 5.2% of portfolio in VERA THERAPEUTICS INC.
The fund managers got completely rid off MERCK & CO INC (MRK), INCYTE CORP (INCY) and ARGENX SE stocks. They significantly reduced their stock positions in INSULET CORP (PODD), IMMATICS N.V and BOSTON SCIENTIFIC CORP (BSX). Sofinnova Investments, Inc. opened new stock positions in EDWARDS LIFESCIENCES CORP (EW), STRYKER CORPORATION (SYK) and RAPPORT THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to INARI MED INC (NARI), BAXTER INTL INC (BAX) and KYVERNA THERAPEUTICS INC.
The top stock holdings of Sofinnova Investments, Inc. are NTRA, VERA, . The fund has invested 8.7% of it's portfolio in NATERA INC and 5.2% of portfolio in VERA THERAPEUTICS INC.
The fund managers got completely rid off MERCK & CO INC (MRK), INCYTE CORP (INCY) and ARGENX SE stocks. They significantly reduced their stock positions in INSULET CORP (PODD), IMMATICS N.V and BOSTON SCIENTIFIC CORP (BSX). Sofinnova Investments, Inc. opened new stock positions in EDWARDS LIFESCIENCES CORP (EW), STRYKER CORPORATION (SYK) and RAPPORT THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to INARI MED INC (NARI), BAXTER INTL INC (BAX) and KYVERNA THERAPEUTICS INC.
Sofinnova Investments, Inc. Equity Portfolio Value
Last Reported on: 09 Aug, 2024
Sofinnova Investments, Inc. Annual Return Estimates Vs S&P 500
Our best estimate is that Sofinnova Investments, Inc. made a return of -8.01% in the last quarter. In trailing 12 months, it's portfolio return was 15.36%.
New Buys
| Ticker | $ Bought |
|---|---|
| edwards lifesciences corp | 66,896,700 |
| stryker corporation | 65,696,800 |
| rapport therapeutics inc | 45,393,300 |
| axsome therapeutics inc | 24,970,900 |
| revolution medicines inc | 17,662,400 |
| insmed inc | 15,259,000 |
| edgewise therapeutics inc | 8,567,200 |
| dexcom inc | 6,972,190 |
New stocks bought by Sofinnova Investments, Inc.
Additions
| Ticker | % Inc. |
|---|---|
| inari med inc | 1,425 |
| baxter intl inc | 488 |
| kyverna therapeutics inc | 378 |
| disc medicine inc | 373 |
| soleno therapeutics inc | 267 |
| ikena oncology inc | 230 |
| establishment labs hldgs inc | 204 |
| marinus pharmaceuticals inc | 196 |
Additions to existing portfolio by Sofinnova Investments, Inc.
Reductions
| Ticker | % Reduced |
|---|---|
| insulet corp | -72.31 |
| immatics n.v | -63.18 |
| boston scientific corp | -51.65 |
| avantor inc | -39.32 |
| intuitive surgical inc | -38.09 |
| celldex therapeutics inc | -31.69 |
| exact sciences corp | -20.77 |
| dyne therapeutics inc | -16.06 |
Sofinnova Investments, Inc. reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| nucana plc | -884,192 |
| incyte corp | -75,609,300 |
| nucana plc | -340,048 |
| inhibrx inc | -45,540,500 |
| silk rd med inc | -21,782,900 |
| merck & co inc | -85,938,900 |
| perspective therapeutics inc | -511,825 |
| fusion pharmaceuticals inc | -3,350,910 |
Sofinnova Investments, Inc. got rid off the above stocks
Sector Distribution
Sofinnova Investments, Inc. has about 76.9% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 76.9 |
| Others | 22.9 |
Market Cap. Distribution
Sofinnova Investments, Inc. has about 35.5% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 35.5 |
| MID-CAP | 24.7 |
| UNALLOCATED | 22.9 |
| SMALL-CAP | 15.3 |
Stocks belong to which Index?
About 53.5% of the stocks held by Sofinnova Investments, Inc. either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 46.4 |
| RUSSELL 2000 | 34.5 |
| S&P 500 | 19 |
Sofinnova Investments, Inc. Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Sofinnova Investments, Inc.
Sofinnova Investments, Inc. has 72 stocks in it's portfolio. About 42.2% of the portfolio is in top 10 stocks. AVTE proved to be the most loss making stock for the portfolio. NTRA was the most profitable stock for Sofinnova Investments, Inc. last quarter.
Last Reported on: 09 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACHV | achieve life sciences inc | 0.34 | 1,388,370 | 6,525,350 | reduced | -8.55 | ||
| ALGN | align technology inc | 2.74 | 218,524 | 52,758,200 | added | 128 | ||
| ALNY | alnylam pharmaceuticals inc | 1.87 | 147,929 | 35,946,700 | added | 43.57 | ||
| AMLX | amylyx pharmaceuticals inc | 0.03 | 299,691 | 569,413 | reduced | -2.29 | ||
| ATXS | astria therapeutics inc | 0.03 | 60,692 | 552,297 | new | |||
| AVTE | aerovate therapeutics inc | 0.32 | 3,758,690 | 6,239,420 | unchanged | 0.00 | ||
| AVTR | avantor inc | 0.16 | 141,045 | 2,990,150 | reduced | -39.32 | ||
| AXNX | axonics inc | 0.53 | 150,490 | 10,117,400 | added | 0.74 | ||
| AXSM | axsome therapeutics inc | 1.30 | 310,198 | 24,970,900 | new | |||
| BAX | baxter intl inc | 0.20 | 117,769 | 3,939,370 | added | 488 | ||
| BOLT | bolt biotherapeutics inc | 0.11 | 2,754,440 | 2,065,830 | unchanged | 0.00 | ||
| BSX | boston scientific corp | 0.69 | 171,080 | 13,174,900 | reduced | -51.65 | ||
| CABA | cabaletta bio inc | 0.47 | 1,220,400 | 9,128,590 | added | 183 | ||
| CLDX | celldex therapeutics inc | 1.05 | 547,707 | 20,270,600 | reduced | -31.69 | ||
| COGT | cogent biosciences inc | 1.22 | 2,773,290 | 23,378,800 | added | 15.52 | ||
| COO | cooper cos inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| DXCM | dexcom inc | 0.36 | 61,494 | 6,972,190 | new | |||
| DYN | dyne therapeutics inc | 2.98 | 1,625,700 | 57,371,100 | reduced | -16.06 | ||
| ELAN | elanco animal health inc | 2.15 | 2,864,250 | 41,331,100 | added | 12.08 | ||
| ERAS | erasca inc | 0.21 | 1,699,530 | 4,010,890 | new | |||